Metabolic-Fit / 100
Lttl review
Compounded semaglutide from $129 a month and tirzepatide from $199, held at the same price at every dose, plus a separate microdose line from $109 for anyone who wants a gentler metabolic effect rather than maximum weight loss. Lttl covers all 50 states and Washington D.C., says it prescribes and ships within 48 hours, and attributes compounding to U.S.A.-licensed pharmacies it does not name. The catalog runs well past weight loss into NAD+, sermorelin, glutathione and B12 from $79, so read the longevity menu as a separate business from the GLP-1 you came for. Prices are published as starting points rather than a single rate, and the first-order discount of up to $140 is promotional.
- HSA / FSA-eligible
- Editor-vetted
- No insurance needed
Referral link, walled off from the score
Elena Voss is a mother writing for mothers, not a treating clinician, and holds no medical license. Every clinical figure in this piece is cited inline to its primary source — the trial or the FDA label — so you can open it and check us. This is background reading, not medical advice.
Lttl at a glance
- Semaglutide
- From $129/mo (floor)
- Tirzepatide
- From $199/mo (floor)
- Coverage
- All 50 states plus Washington D.C.
- Brand-name
- Compounded only
How we scored Lttl
Every factor comes from Lttl's own published pricing, disclosures and oversight, and the six combine into the 56/100 Metabolic-Fit Score by the same weighted six-factor framework we apply to every provider — never nudged by whether a provider pays us.
No postpartum or breastfeeding framing — a generic weight program.
Thin on the hormonal picture that drives many mothers' weight.
Oversight and lab support fall short of the top of this roster — the review below says exactly where.
Cost is unpredictable or sits at the premium end.
Support is thin once the prescription ships.
Exit terms are the weak point: lock-in, notice periods, or a cancellation you have to chase.
How we verified this review
- Last verified
- August 2026
- Confidence
- medium
- Primary source
- lttl.com
Semaglutide from $129 a month and tirzepatide from $199, both held flat at every dose, with a separate microdose line from $109. The word doing the work is 'from' — every figure is a starting point rather than a single published rate, so confirm what your own dose costs before the first charge.
What to expect when you sign up
We walked Lttl's public signup funnel (August 2026) — a first-hand look at the flow. We don't create accounts, enter medical data, or complete checkout, so this is what any visitor sees, not a patient outcome.
- 1The signup call to action stays on lttl.com (https://lttl.com/microdose/quiz)
What we noticed
- The intake runs on Webflow rather than on the provider's own software
- A monthly price is visible on the public homepage before any intake — you do not have to hand over information to see a number
Pricing
Prices re-verified
| Medication | Monthly | Plan |
|---|---|---|
| Compounded semaglutide | $129 | Starting plan, same price at every dose |
| Compounded tirzepatide | $199 | Starting plan, same price at every dose |
Swipe the table to see plan details →
Many HSA and FSA plans cover GLP-1 telehealth — check yours. These figures are what Lttl's own site disclosed at last review; this market re-prices often, so confirm the current number at the source.
What we like
- Same price at every dose, so titrating up never raises the bill
- Publishes a dedicated microdose line from $109 alongside standard dosing
- All 50 states plus Washington D.C., which is wider than most of this roster
- Both molecules on one platform, so switching does not mean switching provider
The caveats
- Every price is a starting point — 'plans start at' — rather than a single published rate
- The up-to-$140 first-order discount is promotional, so the ongoing cost is the number that matters
- Compounding is attributed to U.S.A.-licensed pharmacies that are never named
- Its own terms say some services may not be available in all 50 states, which sits awkwardly beside the 50-state claim
- No postpartum, breastfeeding or PCOS guidance published anywhere on the site
Lttl for mothers: our verdict
Compounded semaglutide from $129 a month and tirzepatide from $199, held at the same price at every dose, plus a separate microdose line from $109 for anyone who wants a gentler metabolic effect rather than maximum weight loss. Lttl covers all 50 states and Washington D.C., says it prescribes and ships within 48 hours, and attributes compounding to U.S.A.-licensed pharmacies it does not name. The catalog runs well past weight loss into NAD+, sermorelin, glutathione and B12 from $79, so read the longevity menu as a separate business from the GLP-1 you came for. Prices are published as starting points rather than a single rate, and the first-order discount of up to $140 is promotional. It runs about $129/month, flat across every dose — toward the affordable end of what we track.
We weigh Lttl the way mothers actually have to: not just the monthly cost, but postpartum and breastfeeding timing and PCOS and insulin resistance — the parts a general weight-loss roundup leaves out.
What Lttl costs, in full
- Compounded semaglutide — Starting plan, same price at every dose: $129/mo
- Compounded tirzepatide — Starting plan, same price at every dose: $199/mo
That sits below the roughly $179 median ongoing price across the providers we track for mothers — a real cost advantage.
Lttl says the price covers the provider visit and the medication. That is the comparison that matters at this price: two providers a few dollars apart can differ by a hundred a month once the extras are counted, so line up what each one bundles before you decide.
The medications Lttl prescribes
Lttl prescribes semaglutide and tirzepatide — the two with the largest published weight-loss effects, and carrying both on one account matters when insulin resistance, common with PCOS and after gestational diabetes, makes tirzepatide the better-suited option. These are compounded formulations from a licensed pharmacy — the reason the price stays down — but compounded GLP-1s aren't FDA-approved finished products the way Wegovy and Zepbound are.
Where Lttl fits — and where it doesn't — for mothers
A good fit if…
- the monthly cost is a real barrier and you want a low, predictable number.
- switching between semaglutide and tirzepatide may become necessary as your body and your hormones change.
- uninterrupted nationwide access matters — a move for family shouldn't interrupt care.
Look elsewhere if…
- you specifically want an FDA-approved brand pen with its own pregnancy and lactation labeling.
- you'd rather a prescriber talk through timing around postpartum and breastfeeding timing — that is the ground our #1 pick, CoreAge Rx, is built on.
Oversight, safety, and what we could verify
Our confidence is moderate — the core facts check out, but some details (per-state availability, program mechanics) aren't fully public. As with any compounded GLP-1, the most useful thing mothers can do is confirm which licensed pharmacy fills the prescription and what's in the formulation — we explain how we weigh oversight in our scoring methodology.
A standing caveat for mothers: GLP-1 medications aren't established as safe during pregnancy or breastfeeding, and every label advises against use. Nothing here changes that — plan the timing with your own clinician.
The bottom line
Lttl is a genuine value play — weigh it on postpartum and breastfeeding timing and PCOS and insulin resistance against the alternatives below. For most mothers, CoreAge Rx remains the stronger all-round fit — see why it tops our ranking.
The bottom line for mothers
Best for: Someone who wants dose-flat pricing or a microdose option and accepts that every figure is a floor.
Alternatives to Lttl
Providers we have a referral relationship with, ordered by their Metabolic-Fit Score — highest first. This module leaves out the provider whose page you are reading, so on CoreAge Rx's own review our #1 pick is the one name you will not find here. These are not the whole roster: see the full ranking for every provider we cover, paid or not.
- Visit CoreAge Rx92
Metabolic-Fit / 100
CoreAge RxOur #1 pickOne flat price, both molecules on a single chart, and a prescriber who reads your history before writing — the most predictable place for a mother to start and, just as important, to pause.
- Visit Gala Health84
Metabolic-Fit / 100
A flat $179 for either molecule with a genuinely gentle microdosing tier — a reasonable, all-doses-included option if you can live with a yearly plan and a pharmacy it doesn't name.
- Visit Enhance MD81
Metabolic-Fit / 100
One of the more oversight-forward compounded programs here — lab work and a live provider visit bundled into every plan, with a gentle microdosing tier — the catch is that the low '$212' headline you'll see quoted is the 12-month prepay rate, not the $249 you'd pay month to month.
Keep comparing Lttl
Head-to-head & alternatives
Lttl, answered
- How much does Lttl cost?
- At last review, Lttl's lowest ongoing compounded rate was about $129 a month — From $129/mo (floor) for semaglutide, From $199/mo (floor) for tirzepatide. This market re-prices often, so check the current all-in figure at the source before committing.
- Is Lttl safe to use while breastfeeding?
- Nothing in this class — compounded or brand — has been established as safe in pregnancy or lactation, and every label advises against use. Lttl is not an exception to that. Plan a GLP-1 for after weaning and settle the timing with your own clinician.
- Does Lttl offer both semaglutide and tirzepatide?
- Yes — Lttl offers both molecules. Tirzepatide's dual GIP/GLP-1 action is often preferred where insulin resistance drives weight, which matters for PCOS and after gestational diabetes.
- Where does Lttl rank for mothers?
- Lttl scores 56/100 on our Metabolic-Fit Score and sits at #40. That score is a weighted read of six things mothers actually have to care about. CoreAge Rx currently leads it — see how they compare.
Pricing, states and verification reflect Lttl's public disclosures at last review; the Metabolic-Fit Score is our editorial judgment per the published methodology. This is background reading, not medical advice — GLP-1 medications are not established as safe in pregnancy or breastfeeding. See our medical disclaimer and how we're funded.